Skip to main content

Table 5 Glaucoma medications usage in both groups

From: Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma

 

Pre-surgery

2 weeks

1 month

3 months

6 months

12 months

Injection Group

2.5 ± 0.5

0.2 ± 0.4

0.6 ± 0.6

0.7 ± 0.6

1.0 ± 0.7

1.1 ± 0.8

Control Group

2.6 ± 0.5

0.2 ± 0.4

0.7 ± 0.7

0.7 ± 0.7

1.1 ± 0.8

1.3 ± 0.9

P

0.66

0.94

0.59

0.93

0.71

0.47

  1. Note: The differences in the number of glaucoma medications used at various time points throughout follow-up were compared between the two groups using the t test
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us